PP01.53 Patient-Reported Outcomes (PROs) in Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC): PERLA Trial Comparing First-Line Chemotherapy Plus Dostarlimab or Pembrolizumab
| Autor: | Reck, Martin, Ortega Granados, Ana Laura, de Marinis, Filippo, Meyers, Oren, Shen, Qin, Cho, Lillian, Boklage, Susan, Gouldin, Winston |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; July 2024, Vol. 19 Issue: 7, Number 7 Supplement 1 pe26-e27, 2p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|